{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:34:40Z","timestamp":1789014880348,"version":"build-2803163510"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2022\/13379-7"],"award-info":[{"award-number":["2022\/13379-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2023\/02132-3"],"award-info":[{"award-number":["2023\/02132-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance code 001"],"award-info":[{"award-number":["Finance code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303534\/2025-7"],"award-info":[{"award-number":["303534\/2025-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s12033-025-01519-0","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:34:09Z","timestamp":1761647649000},"page":"2072-2087","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Physical and Chemical Methods for DNA Vaccine Delivery: Insights into the Melanoma Landscape"],"prefix":"10.1007","volume":"68","author":[{"given":"Amanda","family":"Marante Gimenez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5429-5981","authenticated-orcid":false,"given":"Nat\u00e1lia","family":"Floriano Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9902-6002","authenticated-orcid":false,"given":"Camila","family":"Cubayachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0842-9130","authenticated-orcid":false,"given":"Fabiana","family":"Testa Moura de Carvalho Vicentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"1519_CR1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/pcmr.12933","volume":"34","author":"T Rezaei","year":"2021","unstructured":"Rezaei, T., Davoudian, E., Khalili, S., Amini, M., Hejazi, M., de la Guardia, M., & Mokhtarzadeh, A. (2021). Strategies in DNA vaccine for melanoma cancer. Pigment Cell and Melanoma Research, 34, 869\u2013891.","journal-title":"Pigment Cell and Melanoma Research"},{"key":"1519_CR2","unstructured":"World Health Organization. (2022). International agency for research on cancer (IARC). https:\/\/www.iarc.who.int\/"},{"key":"1519_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold, M., Singh, D., Laversanne, M., Vignat, J., Vaccarella, S., Meheus, F., Cust, A. E., de Vries, E., Whiteman, D. C., & Bray, F. (2022). Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatology, 158, 495\u2013503.","journal-title":"JAMA Dermatology"},{"key":"1519_CR4","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/exd.13309","volume":"26","author":"M Feoktistova","year":"2017","unstructured":"Feoktistova, M., & Panayotova-Dimitrova, D. (2017). Overcoming cell death resistance in skin cancer therapy: Novel translational perspectives. Experimental Dermatology, 26, 854\u2013857.","journal-title":"Experimental Dermatology"},{"key":"1519_CR5","volume":"11","author":"BS Kalal","year":"2017","unstructured":"Kalal, B. S., Upadhya, D., & Pai, V. R. (2017). Chemotherapy resistance mechanisms in advanced skin cancer. Oncology Reviews, 11, Article 326.","journal-title":"Oncology Reviews"},{"key":"1519_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103964","volume":"78","author":"JSR Viegas","year":"2022","unstructured":"Viegas, J. S. R., Bentley, M. V. L. B., & Vicentini, F. T. M. C. (2022). Challenges to perform an efficiently gene therapy adopting non-viral vectors: Melanoma landscape. Journal of Drug Delivery Science and Technology, 78, Article 103964.","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"1519_CR7","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1016\/j.vaccine.2022.03.014","volume":"40","author":"A G\u00fcl","year":"2022","unstructured":"G\u00fcl, A., D\u00f6\u015fkaya, M., Can, H., Karakavuk, M., An\u0131l-\u0130nevi, M., Sa\u011flam-Metiner, P., Atalay-\u015eahar, E., De\u011firmenci-D\u00f6\u015fkaya, A., Zekio\u01e7lu, O., G\u00fcr\u00fcz, Y., G\u00fclce-Iz, S., & Yeniay, L. (2022). Immunogenicity of a xenogeneic multi-epitope HER2+ breast cancer DNA vaccine targeting the dendritic cell restricted antigen-uptake receptor DEC205. Vaccine, 40, 2409\u20132419.","journal-title":"Vaccine"},{"key":"1519_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.168297","volume":"435","author":"S Pagliari","year":"2023","unstructured":"Pagliari, S., Dema, B., Sanchez-Martinez, A., Montalvo Zurbia-Flores, G., & Rollier, C. S. (2023). DNA vaccines: History, molecular mechanisms and future perspectives. Journal of Molecular Biology, 435, Article 168297.","journal-title":"Journal of Molecular Biology"},{"key":"1519_CR9","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.3390\/molecules26113299","volume":"26","author":"L Johannes","year":"2021","unstructured":"Johannes, L. (2021). The cellular and chemical biology of endocytic trafficking and intracellular delivery\u2014the GL-Lect hypothesis. Molecules, 26, 3299.","journal-title":"Molecules"},{"key":"1519_CR10","volume":"15","author":"B Lu","year":"2024","unstructured":"Lu, B., Lim, J. M., Yu, B., Song, S., Neeli, P., Sobhani, N., Prassas, K., Bonam, S. R., Kurapati, R., Zheng, J., & Chai, D. (2024). The next-generation DNA vaccine platforms and delivery systems: Advances, challenges and prospects. Frontiers in Immunology, 15, Article 133293.","journal-title":"Frontiers in Immunology"},{"key":"1519_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/vaccines11020280","volume":"11","author":"C Ledesma-Feliciano","year":"2023","unstructured":"Ledesma-Feliciano, C., Chapman, R., Hooper, J. W., Elma, K., Zehrung, D., Brennan, M. B., & Spiegel, E. K. (2023). Improved DNA vaccine delivery with needle-free injection systems. Vaccines, 11, 280.","journal-title":"Vaccines"},{"issue":"6\u20137","key":"1519_CR12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.biochi.2007.03.001","volume":"89","author":"MA Garcia","year":"2007","unstructured":"Garcia, M. A., Meurs, E. F., & Esteban, M. (2007). The dsRNA protein kinase PKR: Virus and cell control. Biochimie, 89(6\u20137), 799\u2013811.","journal-title":"Biochimie"},{"issue":"7344","key":"1519_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011). A diverse range of gene products are effectors of the type I interferon antiviral response. Nature, 472(7344), 481\u2013485.","journal-title":"Nature"},{"key":"1519_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.7774\/cevr.2024.13.2.73","volume":"13","author":"C Oelkrug","year":"2024","unstructured":"Oelkrug, C. (2024). Analysis of physical and biological delivery systems for DNA cancer vaccines and their translation to clinical development. Clinical and Experimental Vaccine Research, 13, 73.","journal-title":"Clinical and Experimental Vaccine Research"},{"key":"1519_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12951-021-01221-8","volume":"20","author":"P Zhang","year":"2022","unstructured":"Zhang, P., Chen, D., Li, L., & Sun, K. (2022). Charge reversal nano-systems for tumor therapy. Journal of Nanobiotechnology, 20, 31.","journal-title":"Journal of Nanobiotechnology"},{"key":"1519_CR16","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.vaccine.2009.11.014","volume":"28","author":"CM Rush","year":"2010","unstructured":"Rush, C. M., Mitchell, T. J., & Garside, P. (2010). A detailed characterisation of the distribution and presentation of DNA vaccine encoded antigen. Vaccine, 28, 1620\u20131634.","journal-title":"Vaccine"},{"key":"1519_CR17","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.2174\/1381612829666230830105758","volume":"29","author":"P Goyal","year":"2023","unstructured":"Goyal, P., & Malviya, R. (2023). Advancement in polymer-based carrier for DNA vaccine. Current Pharmaceutical Design, 29, 2062\u20132077.","journal-title":"Current Pharmaceutical Design"},{"key":"1519_CR18","doi-asserted-by":"publisher","first-page":"7623","DOI":"10.1093\/nar\/gkaa576","volume":"48","author":"K Deprey","year":"2020","unstructured":"Deprey, K., Batistatou, N., & Kritzer, J. A. (2020). A critical analysis of methods used to investigate the cellular uptake and subcellular localization of RNA therapeutics. Nucleic Acids Research, 48, 7623\u20137639.","journal-title":"Nucleic Acids Research"},{"key":"1519_CR19","doi-asserted-by":"publisher","first-page":"16204","DOI":"10.1021\/acsnano.4c15765","volume":"19","author":"GC Zaccariotto","year":"2025","unstructured":"Zaccariotto, G. C., Bistaffa, M. J., Zapata, A. M. M., Rodero, C., Coelho, F., Quitiba, J. V. B., Lima, L., Sterman, R., Cardoso, V. M. O., & Zucolotto, V. (2025). Cancer nanovaccines: Mechanisms, design principles, and clinical translation. ACS Nano, 19, 16204\u201316223.","journal-title":"ACS Nano"},{"key":"1519_CR20","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMoa050092","volume":"353","author":"JA Curtin","year":"2005","unstructured":"Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K. H., Aiba, S., Br\u00f6cker, E. B., LeBoit, P. E., Pinkel, D., & Bastian, B. C. (2005). Distinct sets of genetic alterations in melanoma. New England Journal of Medicine, 353, 2135\u20132147.","journal-title":"New England Journal of Medicine"},{"key":"1519_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0140-6736(25)00553-7","volume":"406","author":"O Pail","year":"2025","unstructured":"Pail, O., Lin, M. J., Anagnostou, T., Brown, B. D., & Brody, J. D. (2025). Cancer vaccines and the future of immunotherapy. Lancet, 406, 189\u2013202.","journal-title":"Lancet"},{"key":"1519_CR22","doi-asserted-by":"publisher","first-page":"1498431","DOI":"10.3389\/fimmu.2024.1498431","volume":"15","author":"A Shariati","year":"2025","unstructured":"Shariati, A., Khezrpour, A., Shariati, F., Afkhami, H., Yarahmadi, A., Alavimanesh, S., Kamrani, S., Modarressi, M. H., & Khani, P. (2025). DNA vaccines as promising immunotherapeutics against cancer: A new insight. Frontiers in Immunology, 15, 1498431.","journal-title":"Frontiers in Immunology"},{"key":"1519_CR23","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3390\/vaccines3030662","volume":"3","author":"Y Fan","year":"2015","unstructured":"Fan, Y., & Moon, J. J. (2015). Nanoparticle drug delivery systems designed to improve cancer vaccines and immunotherapy. Vaccines, 3, 662\u2013685.","journal-title":"Vaccines"},{"key":"1519_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2174\/2211738507666191024162042","volume":"8","author":"M Kheirollahpour","year":"2020","unstructured":"Kheirollahpour, M., Mehrabi, M., Dounighi, N. M., Mohammadi, M., & Masoudi, A. (2020). Nanoparticles and vaccine development. Pharmaceutical Nanotechnology, 8, 6\u201321.","journal-title":"Pharmaceutical Nanotechnology"},{"key":"1519_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.procbio.2020.09.028","volume":"100","author":"T Zaheer","year":"2021","unstructured":"Zaheer, T., Pal, K., & Zaheer, I. (2021). Topical review on nano-vaccinology: Biochemical promises and key challenges. Process Biochemistry, 100, 237\u2013244.","journal-title":"Process Biochemistry"},{"key":"1519_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2024.04.010","volume":"180","author":"EB Souto","year":"2024","unstructured":"Souto, E. B., Blanco-Llamero, C., Krambeck, K., Kiran, N. S., Yashaswini, C., Postwala, H., Severino, P., Priefer, R., Prajapati, B. G., & Maheshwari, R. (2024). Regulatory insights into nanomedicine and gene vaccine innovation: Safety assessment, challenges, and regulatory perspectives. Acta Biomaterialia, 180, 1\u201317.","journal-title":"Acta Biomaterialia"},{"key":"1519_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nri2868","volume":"10","author":"MF Bachmann","year":"2010","unstructured":"Bachmann, M. F., & Jennings, G. T. (2010). Vaccine delivery: A matter of size, geometry, kinetics and molecular patterns. Nature Reviews Immunology, 10, 787\u2013796.","journal-title":"Nature Reviews Immunology"},{"key":"1519_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s12668-024-01676-7","volume":"15","author":"NF Paiva","year":"2025","unstructured":"Paiva, N. F., Rios, W. M., Antonio, G. P., Umino, G. M., Ferreira, M. P., Brand\u00e3o, I. T., Del Ciampo, J. O., Bentley, M. V. L. B., Casagrande, R., Verri, W. A., Jr., Fonseca, M. J. V., de Freitas, O., Silva, C. L., & Vicentini, F. T. M. C. (2025). Ferritin-based systems as a platform for DNA construct delivery: preparation, characterization, and in vitro evaluation. BioNanoScience, 15, 128.","journal-title":"BioNanoScience"},{"key":"1519_CR29","unstructured":"Food and Drug Administration. (2011). Guidance for industry: clinical considerations for therapeutic cancer vaccines. Food and Drug Administration."},{"key":"1519_CR30","unstructured":"World Health Organization. (2021). Guidelines on the quality, safety and efficacy of plasmid DNA vaccines (Annex 2). WHO Expert Committee on Biological Standardization: seventy-first report. World Health Organization."},{"key":"1519_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123615","volume":"325","author":"Z Zhang","year":"2025","unstructured":"Zhang, Z., Yao, S., Wang, Y., Luo, K., Amiji, M., & Anderson, K. C. (2025). Cancer vaccines: Discovery, development, and challenges for clinical translation. Biomaterials, 325, Article 123615.","journal-title":"Biomaterials"},{"key":"1519_CR32","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.1016\/j.vaccine.2016.09.062","volume":"34","author":"SHT Jorritsma","year":"2016","unstructured":"Jorritsma, S. H. T., Gowans, E. J., Grubor-Bauk, B., & Wijesundara, D. K. (2016). Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines. Vaccine, 34, 5488\u20135494.","journal-title":"Vaccine"},{"key":"1519_CR33","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.1016\/j.vaccine.2015.09.102","volume":"33","author":"KR Porter","year":"2015","unstructured":"Porter, K. R., & Raviprakash, K. (2015). Nucleic acid (DNA) immunization as a platform for dengue vaccine development. Vaccine, 33, 7135\u20137140.","journal-title":"Vaccine"},{"key":"1519_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120598","volume":"602","author":"R Wang","year":"2021","unstructured":"Wang, R., Bian, Q., Xu, Y., Xu, D., & Gao, J. (2021). Recent advances in mechanical force-assisted transdermal delivery of macromolecular drugs. International Journal of Pharmaceutics, 602, Article 120598.","journal-title":"International Journal of Pharmaceutics"},{"key":"1519_CR35","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/j.ijbiomac.2021.05.192","volume":"183","author":"D Sharma","year":"2021","unstructured":"Sharma, D., Arora, S., Singh, J., & Layek, B. (2021). A review of the tortuous path of nonviral gene delivery and recent progress. International Journal of Biological Macromolecules, 183, 2055\u20132073.","journal-title":"International Journal of Biological Macromolecules"},{"key":"1519_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jconrel.2024.01.031","volume":"367","author":"RB So","year":"2024","unstructured":"So, R. B., Li, G., Brentville, V., Daly, J. M., & Dixon, J. E. (2024). Combined biolistic and cell penetrating peptide delivery for the development of scalable intradermal DNA vaccines. Journal of Controlled Release, 367, 209\u2013222.","journal-title":"Journal of Controlled Release"},{"key":"1519_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jconrel.2024.01.036","volume":"367","author":"G Kougkolos","year":"2024","unstructured":"Kougkolos, G., Laudebat, L., Dinculescu, S., Simon, J., Golzio, M., Valdez-Nava, Z., & Flahaut, E. (2024). Skin electroporation for transdermal drug delivery: Electrical measurements, numerical model and molecule delivery. Journal of Controlled Release, 367, 235\u2013247.","journal-title":"Journal of Controlled Release"},{"key":"1519_CR38","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.3390\/cancers12082208","volume":"12","author":"A Kie\u0142bik","year":"2020","unstructured":"Kie\u0142bik, A., Szlasa, W., Saczko, J., & Kulbacka, J. (2020). Electroporation-based treatments in urology. Cancers, 12, 2208.","journal-title":"Cancers"},{"key":"1519_CR39","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1080\/14760584.2021.1984890","volume":"20","author":"A Das","year":"2021","unstructured":"Das, A., & Ali, N. (2021). Nanovaccine: An emerging strategy. Expert Review of Vaccines, 20, 1273\u20131290.","journal-title":"Expert Review of Vaccines"},{"key":"1519_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/hgtb.2017.105","volume":"29","author":"K Schultheis","year":"2018","unstructured":"Schultheis, K., Smith, T. R. F., Kiosses, W. B., Kraynyak, K. A., Wong, A., Oh, J., & Broderick, K. E. (2018). Delineating the cellular mechanisms associated with skin electroporation. Human Gene Therapy Methods, 29, 177\u2013188.","journal-title":"Human Gene Therapy Methods"},{"key":"1519_CR41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.actbio.2022.06.046","volume":"149","author":"SS Yerneni","year":"2022","unstructured":"Yerneni, S. S., Yalcintas, E. P., Smith, J. D., Averick, S., Campbell, P. G., & Ozdoganlar, O. B. (2022). Skin-targeted delivery of extracellular vesicle-encapsulated curcumin using dissolvable microneedle arrays. Acta Biomaterialia, 149, 198\u2013212.","journal-title":"Acta Biomaterialia"},{"key":"1519_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2202269","volume":"12","author":"F Fan","year":"2023","unstructured":"Fan, F., Zhang, X., Zhang, Z., Ding, Y., Wang, L., Xu, X., Pan, Y., Gong, F. Y., Jiang, L., Kang, L., Ha, Z., Lu, H., Hou, J., Kou, Z., Zhao, G., Wang, B., & Gao, X. M. (2023). Potent immunogenicity and broad-spectrum protection potential of microneedle array patch-based COVID-19 DNA vaccine candidates encoding dimeric RBD chimera of SARS-CoV and SARS-CoV-2 variants. Emerging Microbes and Infections, 12, Article 2202269.","journal-title":"Emerging Microbes and Infections"},{"key":"1519_CR43","first-page":"3774","volume":"65","author":"SBVJ Chinna","year":"2022","unstructured":"Chinna, S. B. V. J., & Mannayee, G. (2022). Structural analysis and simulation of solid microneedle array for vaccine delivery applications. Materials Today, 65, 3774\u20133779.","journal-title":"Materials Today"},{"key":"1519_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10662","volume":"9","author":"CY Lu","year":"2024","unstructured":"Lu, C. Y., Rohilla, P., Felner, E. I., Byagathvalli, G., Azizoglu, E., Bhamla, M. S., & Prausnitz, M. R. (2024). Tolerability of a piezoelectric microneedle electroporator in human subjects. Bioengineering and Translational Medicine, 9, Article e10662.","journal-title":"Bioengineering and Translational Medicine"},{"key":"1519_CR45","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1111\/1759-7714.14217","volume":"12","author":"Z Xia","year":"2021","unstructured":"Xia, Z., Qing, B., Wang, W., Gu, L., Chen, H., & Yuan, Y. (2021). Formation, contents, functions of exosomes and their potential in lung cancer diagnostics and therapeutics. Thoracic Cancer, 12, 3088\u20133100.","journal-title":"Thoracic Cancer"},{"key":"1519_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001179","volume":"9","author":"X Hao","year":"2021","unstructured":"Hao, X., Falo Iii, L. D., Chen, G., Zhang, J., Carey, C. D., Storkus, W. J., Falo, L. D., Jr., & You, Z. (2021). Skin immunization for effective treatment of multifocal melanoma refractory to PD1 blockade and Braf inhibitors. Journal for Immunotherapy of Cancer, 9, Article e001179.","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"1519_CR47","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1159\/000537896","volume":"47","author":"MH Geukes Foppen","year":"2024","unstructured":"Geukes Foppen, M. H., Rohaan, M. W., Borgers, J. S. W., Philips, D., Vyth-Dreese, F., Beijnen, J. H., Nuijen, B., van den Berg, J. H., & Haanen, J. B. A. G. (2024). Intradermal naked DNA vaccination by DNA tattooing for mounting tumor-specific immunity in stage IV melanoma patients: A phase I clinical trial. Oncology Research and Treatment, 47, 351\u2013359.","journal-title":"Oncology Research and Treatment"},{"key":"1519_CR48","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1039\/C9TB02175B","volume":"8","author":"HTT Duong","year":"2020","unstructured":"Duong, H. T. T., Yin, Y., Thambi, T., Kim, B. S., Jeong, J. H., & Lee, D. S. (2020). Highly potent intradermal vaccination by an array of dissolving microneedle polypeptide cocktails for cancer immunotherapy. Journal of Materials Chemistry B, 8, 1171\u20131181.","journal-title":"Journal of Materials Chemistry B"},{"key":"1519_CR49","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1038\/s41467-023-41013-2","volume":"14","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z., Feng, Z., Zhao, X., Jean, D., Yu, Z., & Chapman, E. R. (2023). Functionalization and higher-order organization of liposomes with DNA nanostructures. Nature Communications, 14, 5256.","journal-title":"Nature Communications"},{"key":"1519_CR50","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/vaccines11030661","volume":"11","author":"B Karunakaran","year":"2023","unstructured":"Karunakaran, B., Gupta, R., Patel, P., Salave, S., Sharma, A., Desai, D., Benival, D., & Kommineni, N. (2023). Emerging trends in lipid-based vaccine delivery: A special focus on developmental strategies, fabrication methods, and applications. Vaccines, 11, 661.","journal-title":"Vaccines"},{"key":"1519_CR51","doi-asserted-by":"publisher","first-page":"17996","DOI":"10.1021\/acsnano.3c04333","volume":"17","author":"JW Dittmar","year":"2023","unstructured":"Dittmar, J. W., Teplensky, M. H., Evangelopoulos, M., Qin, L., Zhang, B., & Mirkin, C. A. (2023). Tuning DNA dissociation from spherical nucleic acids for enhanced immunostimulation. ACS Nano, 17, 17996\u201318007.","journal-title":"ACS Nano"},{"key":"1519_CR52","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/tbed.13718","volume":"68","author":"CA Kornuta","year":"2021","unstructured":"Kornuta, C. A., Bidart, J. E., Soria, I., Gammella, M., Quattrocchi, V., Pappalardo, J. S., Salmaso, S., Torchilin, V. P., Cheuquep\u00e1n Valenzuela, F., Hecker, Y. P., Moore, D. P., Zamorano, P. I., & Langellotti, C. A. (2021). MAN\u03b11-2MAN decorated liposomes enhance the immunogenicity induced by a DNA vaccine against BoHV-1. Transboundary And Emerging Diseases, 68, 587\u2013597.","journal-title":"Transboundary And Emerging Diseases"},{"key":"1519_CR53","doi-asserted-by":"crossref","unstructured":"Athaydes Seabra Ferreira, H., Ricardo Aluotto Scalzo J\u00fanior, S., Kelton Santos de Faria, K., Henrique Costa Silva, G., T\u00fallio Rodrigues Alves, M., Oliveira Lobo, A. and Pires Goulart Guimar\u00e3es, P. (2024) Cryoprotectant optimization for enhanced stability and transfection efficiency of pDNA-loaded ionizable lipid nanoparticles. Int. J. Pharm. 665, 124696.","DOI":"10.1016\/j.ijpharm.2024.124696"},{"key":"1519_CR54","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/vaccines12060666","volume":"12","author":"M Li","year":"2024","unstructured":"Li, M., Liu, L., Li, X., Li, J., Zhao, C., Zhao, Y., Zhang, X., He, P., Wu, X., Jiang, S., Wang, X., Zhang, X., & Wei, L. (2024). Lipid nanoparticles outperform electroporation in delivering therapeutic HPV DNA vaccines. Vaccines, 12, 666.","journal-title":"Vaccines"},{"key":"1519_CR55","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1021\/acsami.3c14714","volume":"16","author":"M Maeki","year":"2024","unstructured":"Maeki, M., Uno, S., Sugiura, K., Sato, Y., Fujioka, Y., Ishida, A., Ohba, Y., Harashima, H., & Tokeshi, M. (2024). Development of polymer-lipid hybrid nanoparticles for large-sized plasmid DNA transfection. ACS Applied Materials and Interfaces, 16, 2110\u20132119.","journal-title":"ACS Applied Materials and Interfaces"},{"key":"1519_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122914","volume":"638","author":"Z Guo","year":"2023","unstructured":"Guo, Z., Jing, Q., Xu, Z., Zhang, D., Zheng, W., & Ren, F. (2023). Corosolic acid-modified lipid nanoparticles as delivery carriers for DNA vaccines against avian influenza. International Journal of Pharmaceutics, 638, Article 122914.","journal-title":"International Journal of Pharmaceutics"},{"key":"1519_CR57","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.ijbiomac.2020.10.010","volume":"165","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z., Li, D., Ma, X., Li, X., Guo, Z., Liu, Y., & Zheng, S. (2020). Carboxylated nanodiamond-mediated NH2-PLGA nanoparticle-encapsulated fig polysaccharides for strongly enhanced immune responses in vitro and in vivo. International Journal of Biological Macromolecules, 165, 1331\u20131345.","journal-title":"International Journal of Biological Macromolecules"},{"key":"1519_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104061","volume":"142","author":"H Zheng","year":"2020","unstructured":"Zheng, H., Pan, L., Lv, J., Zhang, Z., Wang, Y., Hu, W., Liu, X., Zhou, P., Wang, Y., & Zhang, Y. (2020). Comparison of immune responses in guinea pigs by intranasal delivery with different nanoparticles-loaded FMDV DNA vaccine. Microbial Pathogenesis, 142, Article 104061.","journal-title":"Microbial Pathogenesis"},{"key":"1519_CR59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.rvsc.2021.02.010","volume":"136","author":"Y Yang","year":"2021","unstructured":"Yang, Y., Teng, Z., Lu, Y., Luo, X., Mu, S., Ru, J., Zhao, X., Guo, H., Ran, X., Wen, X., & Sun, S. (2021). Enhanced immunogenicity of foot and mouth disease DNA vaccine delivered by PLGA nanoparticles combined with cytokine adjuvants. Research in Veterinary Science, 136, 89\u201396.","journal-title":"Research in Veterinary Science"},{"key":"1519_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2019.110294","volume":"106","author":"Y Lu","year":"2020","unstructured":"Lu, Y., Wu, F., Duan, W., Mu, X., Fang, S., Lu, N., Zhou, X., & Kong, W. (2020). Engineering a \u201cPEG-g-PEI\/DNA nanoparticle-in-PLGA microsphere\u201d hybrid controlled release system to enhance immunogenicity of DNA vaccine. Materials Science and Engineering C, Materials for Biological Applications, 106, Article 110294.","journal-title":"Materials Science and Engineering C, Materials for Biological Applications"},{"key":"1519_CR61","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12985-021-01536-w","volume":"18","author":"XB Liu","year":"2021","unstructured":"Liu, X. B., Yu, G. W., Gao, X. Y., Huang, J. L., Qin, L. T., Ni, H. B., & Lyu, C. (2021). Intranasal delivery of plasmids expressing bovine herpesvirus 1 gB\/gC\/gD proteins by polyethyleneimine magnetic beads activates long-term immune responses in mice. Virology Journal, 18, 60.","journal-title":"Virology Journal"},{"key":"1519_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123959","volume":"654","author":"D Eus\u00e9bio","year":"2024","unstructured":"Eus\u00e9bio, D., Paul, M., Biswas, S., Cui, Z., Costa, D., & Sousa, \u00c2. (2024). Mannosylated polyethylenimine-cholesterol-based nanoparticles for targeted delivery of minicircle DNA vaccine against COVID-19 to antigen-presenting cells. International Journal of Pharmaceutics, 654, Article 123959.","journal-title":"International Journal of Pharmaceutics"},{"key":"1519_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.112219","volume":"210","author":"J Sabin","year":"2022","unstructured":"Sabin, J., Alatorre-Meda, M., Mi\u00f1ones, J., Dom\u00ednguez-Arca, V., & Prieto, G. (2022). New insights on the mechanism of polyethylenimine transfection and their implications on gene therapy and DNA vaccines. Colloids and Surfaces B: Biointerfaces, 210, Article 112219.","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"1519_CR64","doi-asserted-by":"publisher","first-page":"24200","DOI":"10.1021\/acsnano.3c09521","volume":"17","author":"M Li","year":"2023","unstructured":"Li, M., Yang, L., Wang, C., Cui, M., Wen, Z., Liao, Z., Han, Z., Zhao, Y., Lang, B., Chen, H., Qian, J., Shu, Y., Zeng, X., & Sun, C. (2023). Rapid induction of long-lasting systemic and mucosal immunity via thermostable microneedle-mediated chitosan oligosaccharide-encapsulated DNA nanoparticles. ACS Nano, 17, 24200\u201324217.","journal-title":"ACS Nano"},{"key":"1519_CR65","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.vaccine.2023.02.046","volume":"41","author":"E Hosseinnezhad-Lazarjani","year":"2023","unstructured":"Hosseinnezhad-Lazarjani, E., Doosti, A., & Sharifzadeh, A. (2023). Novel csuC-DNA nanovaccine based on chitosan candidate vaccine against infection with Acinetobacter baumannii. Vaccine, 41, 2170\u20132183.","journal-title":"Vaccine"},{"key":"1519_CR66","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1109\/TNB.2021.3092307","volume":"21","author":"CC Mendoza-Guevara","year":"2022","unstructured":"Mendoza-Guevara, C. C., Ramon-Gallegos, E., Martinez-Escobar, A., Alonso-Morales, R., Ramos-Godinez, M. D. P., & Ortega, J. (2022). Attachment and in vitro transfection efficiency of an anti-Rabies chitosan-DNA nanoparticle vaccine. IEEE Transactions on NanoBioscience, 21, 105\u2013116.","journal-title":"IEEE Transactions on NanoBioscience"},{"key":"1519_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104560","volume":"149","author":"F Bande","year":"2020","unstructured":"Bande, F., Arshad, S. S., Bejo, M. H., Omar, A. R., Moeini, H., Khadkodaei, S., Wei, T. S., Keong, Y. S., Abba, Y., & Anka, I. A. (2020). Development and immunogenic potentials of chitosan-saponin encapsulated DNA vaccine against avian infectious bronchitis coronavirus. Microbial Pathogenesis, 149, Article 104560.","journal-title":"Microbial Pathogenesis"},{"key":"1519_CR68","doi-asserted-by":"publisher","first-page":"17582","DOI":"10.1021\/acsnano.1c05002","volume":"15","author":"US Kumar","year":"2021","unstructured":"Kumar, U. S., Afjei, R., Ferrara, K., Massoud, T. F., & Paulmurugan, R. (2021). Gold-nanostar-chitosan-mediated delivery of SARS-CoV-2 DNA vaccine for respiratory mucosal immunization: Development and proof-of-principle. ACS Nano, 15, 17582\u201317601.","journal-title":"ACS Nano"},{"key":"1519_CR69","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/pharmaceutics13050673","volume":"13","author":"AS Serra","year":"2021","unstructured":"Serra, A. S., Eus\u00e9bio, D., Neves, A. R., Albuquerque, T., Bhatt, H., Biswas, S., Costa, D., & Sousa, \u00c2. (2021). Synthesis and characterization of mannosylated formulations to deliver a minicircle DNA vaccine. Pharmaceutics, 13, 673.","journal-title":"Pharmaceutics"},{"key":"1519_CR70","doi-asserted-by":"publisher","first-page":"1066268","DOI":"10.3389\/fimmu.2022.1066268","volume":"13","author":"Y Feng","year":"2023","unstructured":"Feng, Y., Tang, F., Li, S., Wu, D., Liu, Q., Li, H., Zhang, X., Liu, Z., Zhang, L., & Feng, H. (2023). Mannose-modified erythrocyte membrane-encapsulated chitovanic nanoparticles as a DNA vaccine carrier against reticuloendothelial tissue hyperplasia virus. Frontiers in Immunology, 13, 1066268.","journal-title":"Frontiers in Immunology"},{"key":"1519_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2022.198896","volume":"320","author":"Z Zhao","year":"2022","unstructured":"Zhao, Z., Jiang, F. Y., Zhou, G. Q., Duan, H. X., Xia, J. Y., & Zhu, B. (2022). Protective immunity against spring viremia of carp virus by mannose modified chitosan loaded DNA vaccine. Virus Research, 320, Article 198896.","journal-title":"Virus Research"},{"key":"1519_CR72","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/cbic.202000364","volume":"22","author":"G Moku","year":"2021","unstructured":"Moku, G., Vangala, S., Gulla, S. K., & Yakati, V. (2021). In vivo targeting of DNA vaccines to dendritic cells via the mannose receptor induces long-lasting immunity against melanoma. ChemBioChem, 22, 523\u2013531.","journal-title":"ChemBioChem"},{"key":"1519_CR73","doi-asserted-by":"publisher","first-page":"14015","DOI":"10.1021\/acsami.1c01401","volume":"13","author":"B Sun","year":"2021","unstructured":"Sun, B., Zhao, X., Wu, Y., Cao, P., Movahedi, F., Liu, J., Wang, J., Xu, Z. P., & Gu, W. (2021). Mannose-functionalized biodegradable nanoparticles efficiently deliver DNA vaccine and promote anti-tumor immunity. ACS Applied Materials and Interfaces, 13, 14015\u201314027.","journal-title":"ACS Applied Materials and Interfaces"},{"key":"1519_CR74","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fimmu.2019.00059","volume":"10","author":"AB Zaneti","year":"2019","unstructured":"Zaneti, A. B., Yamamoto, M. M., Sulczewski, F. B., Almeida, B. D. S., Souza, H. F. S., Ferreira, N. S., Maeda, D. L. N. F., Sales, N. S., Rosa, D. S., Ferreira, L. C. S., & Boscardin, S. B. (2019). Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein domain III. Frontiers in Immunology, 10, 59.","journal-title":"Frontiers in Immunology"},{"key":"1519_CR75","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00262-019-02471-0","volume":"69","author":"JT Gordy","year":"2020","unstructured":"Gordy, J. T., Luo, K., Kapoor, A., Kim, E. S., Ayeh, S. K., Karakousis, P. C., & Markham, R. B. (2020). Treatment with an immature dendritic cell-targeting vaccine supplemented with IFN-\u03b1 and an inhibitor of DNA methylation markedly enhances survival in a murine melanoma model. Cancer Immunology, Immunotherapy, 69, 569\u2013580.","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"1519_CR76","doi-asserted-by":"publisher","first-page":"1063129","DOI":"10.3389\/fimmu.2022.1063129","volume":"13","author":"H Xu","year":"2022","unstructured":"Xu, H., Li, L., Li, R., Guo, Z., Lin, M., Lu, Y., Hou, J., Govinden, R., Deng, B., & Chenia, H. Y. (2022). Evaluation of dendritic cell-targeting T7 phages as a vehicle to deliver avian influenza virus H5 DNA vaccine in SPF chickens. Frontiers In Immunology, 13, 1063129.","journal-title":"Frontiers In Immunology"},{"key":"1519_CR77","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1038\/s41598-018-38080-7","volume":"9","author":"A Lys\u00e9n","year":"2019","unstructured":"Lys\u00e9n, A., Braathen, R., Gudjonsson, A., Tesfaye, D. Y., Bogen, B., & Fossum, E. (2019). Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site. Scientific Reports, 9, 1820.","journal-title":"Scientific Reports"},{"key":"1519_CR78","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.1039\/D3BM00702B","volume":"11","author":"S Barui","year":"2023","unstructured":"Barui, S., Saha, S., Venu, Y., Moku, G. K., & Chaudhuri, A. (2023). In vivo targeting of a tumor-antigen encoded DNA vaccine to dendritic cells in combination with tumor-selective chemotherapy eradicates established mouse melanoma. Biomaterials Science, 11, 6135\u20136148.","journal-title":"Biomaterials Science"},{"key":"1519_CR79","doi-asserted-by":"publisher","first-page":"5148","DOI":"10.1021\/acs.biomac.2c00993","volume":"23","author":"F Bellato","year":"2022","unstructured":"Bellato, F., Feola, S., Dalla Verde, G., Bellio, G., Pirazzini, M., Salmaso, S., Caliceti, P., Cerullo, V., & Mastrotto, F. (2022). Mannosylated polycations target CD206+ antigen-presenting cells and mediate T-cell-specific activation in cancer vaccination. Biomacromolecules, 23, 5148\u20135163.","journal-title":"Biomacromolecules"},{"key":"1519_CR80","doi-asserted-by":"publisher","first-page":"1074644","DOI":"10.3389\/fimmu.2022.1074644","volume":"13","author":"JT Gordy","year":"2023","unstructured":"Gordy, J. T., Sandhu, A. K., Fessler, K., Luo, K., Kapoor, A. R., Ayeh, S. K., Hui, Y., Schill, C., Chen, F., Wang, T., Karanika, S., Sunshine, J. C., Karakousis, P. C., & Markham, R. B. (2023). IFN\u03b1 and 5-Aza-2\u2019-deoxycytidine combined with a dendritic-cell targeting DNA vaccine alter tumor immune cell infiltration in the B16F10 melanoma model. Frontiers in Immunology, 13, 1074644.","journal-title":"Frontiers in Immunology"},{"key":"1519_CR81","doi-asserted-by":"publisher","first-page":"4045760","DOI":"10.1155\/2020\/4045760","volume":"2020","author":"C Robles-Planells","year":"2020","unstructured":"Robles-Planells, C., Barrera-Avalos, C., Rojo, L. E., Spencer, E., Cortez-San Martin, M., Matiacevich, S., Pavez, J., Milla, L. A., Navarro, F. D., Mart\u00ednez, B. A., Bravo, F. J., Mella, A., Huidobro-Toro, J. P., Fernandez, R., Escobar, A., & Castillo, C. A. (2020). Chitosan-Based delivery of avian reovirus fusogenic protein p10 gene: In vitro and in vivo studies towards a new vaccine against melanoma. BioMed Research International, 2020, 4045760.","journal-title":"BioMed Research International"},{"key":"1519_CR82","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1080\/10717544.2021.1895904","volume":"28","author":"Y Kodama","year":"2021","unstructured":"Kodama, Y., Tokunaga, A., Hashizume, J., Nakagawa, H., Harasawa, H., Kurosaki, T., Nakamura, T., Nishida, K., Nakashima, M., Hashida, M., Kawakami, S., & Sasaki, H. (2021). Evaluation of transgene expression characteristics and DNA vaccination against melanoma metastasis of an intravenously injected ternary complex with biodegradable dendrigraft poly-L-lysine in mice. Drug Delivery, 28, 542\u2013549.","journal-title":"Drug Delivery"},{"key":"1519_CR83","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.omtn.2021.09.006","volume":"26","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Huang, Y., Huang, H., Luo, Z., Zhang, Z., Sun, R., Wan, Z., Sun, J., Lu, B., & Li, S. (2021). Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination. Molecular Therapy. Nucleic Acids, 26, 594\u2013602.","journal-title":"Molecular Therapy. Nucleic Acids"},{"key":"1519_CR84","doi-asserted-by":"publisher","first-page":"1072810","DOI":"10.3389\/fimmu.2023.1072810","volume":"14","author":"NJ Tursi","year":"2023","unstructured":"Tursi, N. J., Xu, Z., Helble, M., Walker, S., Liaw, K., Chokkalingam, N., Kannan, T., Wu, Y., Tello-Ruiz, E., Park, D. H., Zhu, X., Wise, M. C., Smith, T. R. F., Majumdar, S., Kossenkov, A., Kulp, D. W., & Weiner, D. B. (2023). Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo. Frontiers in Immunology, 14, 1072810.","journal-title":"Frontiers in Immunology"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-025-01519-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-025-01519-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-025-01519-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:02:20Z","timestamp":1779800540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-025-01519-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1519"],"URL":"https:\/\/doi.org\/10.1007\/s12033-025-01519-0","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}